Assessing the Effect of an Antioxidant-Rich Diet on Metabolic Syndrome Risk Using the Dietary Antioxidant Index

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-45
SponsorUniversity of Veterinary and Animal Sciences, Lahore - Pakistan

About this trial

Metabolic syndrome (MetS) is a cluster of metabolic disorders characterized by elevated levels of blood glucose, hypertension, dyslipidemia, and abdominal obesity. Globally, it is a major public health concern. International studies have linked higher Dietary Antioxidant Index with reduced risk of MetS, as antioxidants play a role in lowering the risk of MetS by reducing oxidative stress, a key contributor to its pathophysiology. Exploring this link in Pakistan can provide valuable insights for dietary strategies to reduce the risk of MetS.

Eligibility criteria

Qualifiers

Adults aged 18-45 years

Metabolic syndrome risk (abdominal obesity & elevated BP as per NCEP ATP III criteria).

Low fruit & veg intake (<5 serv./day) as per WHO.

Willing to follow an intervention

Disqualifiers

Individuals < 18 years or > 45 years

Not at risk of metabolic syndrome.

Adequate intake of fruits & veg (≥ 5 serv./day) as per WHO

Not willing

Trial design

Treatments tested in this trial

  • Antioxidant-Focused Diet Intervention

Treatment groups

55 Participants
are divided into 1 treatment group